Get the Stockscreener App
3.16
6.78%
-0.23
After Hours:
3.16
Onconetix Inc stock is traded at $3.16, with a volume of 77,187.
It is down -6.78% in the last 24 hours and up +1.28% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$3.39
Open:
$3.28
24h Volume:
77,187
Relative Volume:
0.55
Market Cap:
$4.88M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.029
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
-11.24%
1M Performance:
+1.28%
6M Performance:
-46.74%
1Y Performance:
-98.72%
1-Day Range:
$2.85
$3.325
1-Week Range:
$2.85
$4.00
52-Week Range:
$2.45
$251.60
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.16 | 5.27M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Onconetix Inc Stock (ONCO) Latest News
Why Onconetix Inc. stock is considered a top pickJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - newser.com
Market reaction to Onconetix Inc.’s recent newsJuly 2025 Trends & Verified Momentum Watchlists - newser.com
Order flow analysis tools used on Onconetix Inc.Weekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
Can you recover from losses in Onconetix Inc.Portfolio Gains Report & Daily Technical Forecast Reports - newser.com
Is Onconetix Inc. (J4T) stock worth holding before Fed meetingBull Run & Risk Controlled Stock Pick Alerts - newser.com
Is Onconetix Inc. (J4T) stock resilient in recession scenariosGold Moves & Fast Exit Strategy with Risk Control - newser.com
Is Onconetix Inc. (J4T) stock a defensive play amid uncertainty2025 Macro Impact & Daily Volume Surge Signals - newser.com
What catalysts could drive Onconetix Inc. stock higher2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com
Is Onconetix Inc. stock reversal real or fakeJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
What hedge fund activity signals for Onconetix Inc. stockJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Is Onconetix Inc. (J4T) stock nearing a technical breakoutPortfolio Risk Report & Reliable Entry Point Trade Alerts - newser.com
What’s the recovery path for long term holders of Onconetix Inc.Weekly Loss Report & Reliable Intraday Trade Plans - newser.com
How to forecast Onconetix Inc. trends using time series2025 Trading Recap & AI Driven Price Predictions - newser.com
Analyzing net buyer seller activity in Onconetix Inc.Market Risk Analysis & Consistent Profit Trading Strategies - newser.com
Can technical indicators confirm Onconetix Inc.’s reversalEarnings Beat & Reliable Trade Execution Plans - newser.com
How Onconetix Inc. (J4T) stock trades after rate cutsJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - newser.com
Is Onconetix Inc. stock a smart buy before Fed meetingRate Cut & High Win Rate Trade Tips - newser.com
Will Onconetix Inc. stock maintain momentum in 20252025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Will Onconetix Inc. (J4T) stock announce special dividendBear Alert & Low Drawdown Momentum Trade Ideas - newser.com
What analysts say about Onconetix Inc stockStock Market Trends & Let Our AI Be Your Trading Assistant - earlytimes.in
Tools to assess Onconetix Inc.’s risk profile2025 Market Overview & Low Risk Growth Stock Ideas - newser.com
Real time social sentiment graph for Onconetix Inc.Weekly Profit Summary & Low Risk High Win Rate Picks - newser.com
What Fibonacci levels say about Onconetix Inc. reboundJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Using Bollinger Bands to evaluate Onconetix Inc.Weekly Profit Recap & Reliable Volume Spike Alerts - newser.com
Why analysts upgrade Onconetix Inc. stockMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Onconetix Announces 2025 Annual Meeting Details - The Globe and Mail
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):